The pharmaceutical laboratory wants to significantly increase its research and development expenses and its production capacity throughout the Atlantic.
Sanofi on Wednesday announced its intention to invest at least $ 20 billion (17.88 billion euros) in the United States for 2030 to significantly increase its research and development expenses and its production capacity in the country.
The investment decisions of the pharmaceutical laboratory will be adjusted in accordance with the evolution of the external environment and investments should create a significant number of well -paid works in several states in the coming years, Sanofi said in a press release.
>> More information to come to BFM Business in a few moments. Also find the live BFM business on video and follow us on Twitter.
Source: BFM TV
